POC(Point-of-Care) ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ¿ëµµº°, ±â¼úº°, °Ë»ç ±â¹Ýº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology, By Test Location, By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1405886
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

POC(Point-of-Care) ºÐÀÚÁø´Ü ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ POC(Point-of-Care) ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð´Â 2024-2030³â CAGR 2.5%¸¦ ±â·ÏÇϸç, 2030³â¿¡´Â 101¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

COVID-19, HIV, HBC, HCV¿Í °°Àº °¨¿°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ë·É Àα¸ Áõ°¡´Â POC ºÐÀÚÁø´Ü °Ë»çÀÇ Çʿ伺À» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ POC °Ë»ç°¡ Á¦°øÇÏ´Â ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú´Â Áö¿ª Àüü¿¡¼­ ¼ö¿ëÀÌ È®´ëµÇ´Â ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ±¹°¡¿¡¼­ ÀçÅÃÄ¡·á ¹× ¿ä¾ç ½Ã¼³ÀÇ Á߿伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß POC ºÐÀÚÁø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ³ë·É Àα¸°¡ Áõ°¡Çϸ鼭 POC ºÐÀÚÁø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ Ã߻꿡 µû¸£¸é ¼¼°è 65¼¼ ÀÌ»ó Àα¸´Â 2000³â 7%¿¡¼­ 2050³â 16%±îÁö Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í·ÉÈ­´Â ½ÉÇ÷°ü Áúȯ, ¾Ï µî Áúº´ À§ÇèÀ» Áõ°¡½Ãŵ´Ï´Ù. µû¶ó¼­ Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ÀçÅÃÄ¡·á ¹× »ýȰ Áö¿ø ÀÇ·á ½Ã¼³°ú °°ÀÌ POC MDx°¡ ÇÊ¿äÇÑ ½Ã¼³À» ÅëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀϺ»°ú Áß±¹Àº °¡Àå Å« ¿µÇâÀ» ¹Þ´Â ¾Æ½Ã¾Æ ±¹°¡ Áß ÇϳªÀ̸ç, ÀϺ»ÀÇ ³ëÀÎ Àα¸°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇöÀç ÀϺ» Àα¸ÀÇ 20% ÀÌ»óÀÌ 65¼¼ ÀÌ»óÀÔ´Ï´Ù.

°¢±¹ÀÇ ¾Ï À¯º´·ü Áõ°¡´Â º´¿ø³» POC(Point-of-Care) ºÐÀÚÁø´Ü °Ë»ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¾Ï ȯÀÚ ¼ö´Â 2015³â 153¸¸ ¸í¿¡¼­ 2050³â 228¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¾Ï Áø´ÜÀ» À§ÇÑ CRISPR°ú NGS ±â¼úÀÇ µîÀåÀº Áø´ÜÀ²À» ºñ¾àÀûÀ¸·Î Çâ»ó½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ Áö³­ 10³â°£ NGSÀÇ °¡°ÝÀÌ Àú·ÅÇØÁø °Íµµ ¾Ï ¿µ¿ªÀÇ POC ºÐÀÚÁø´Ü ½ÃÀå¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¼¼°è ½ÃÀåÀ» ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

POC ºÐÀÚÁø´Ü ½ÃÀå¿¡ ÁøÃâÇÑ ÁÖ¿ä ±â¾÷À¸·Î´Â ´Ù³ªÇã, ¹ÙÀÌ¿À¸ÅÆ®¸®¾ó, ¹ÙÀÌ¿À ·¡µå ¿¬±¸¼Ò, ¾Öº¸Æ®, F. È£ÇÁ¸¸ ¶ó ·Î½´, BD µîÀÌ ÀÖ½À´Ï´Ù. ¸¹Àº ÆÄÀÏ·µ ÇÁ·Î±×·¥ÀÌ ½ÃÀÛµÇ°í »õ·Î¿î Á¦Ç°ÀÌ ½ÃÀå¿¡ Ãâ½ÃµÉ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 3¿ù Intermountain Healthcare´Â 50¸íÀÇ Á÷¿øÀ» ´ë»óÀ¸·Î Galleri Multi-Cancer Early Detection Test¸¦ ½Ã¹üÀûÀ¸·Î ¹èÆ÷ÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

POC(Point-of-Care) ºÐÀÚÁø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå ±â¼ú ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦6Àå °Ë»ç ±â¹Ý ºñÁî´Ï½º ºÐ¼®

Á¦7Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦8Àå Áö¿ªÀÇ ºñÁî´Ï½º ºÐ¼®

Á¦9Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Point-of-Care Molecular Diagnostics Market Growth & Trends:

The global point-of-care molecular diagnostics market size is expected to reach USD 10.12 billion by 2030, registering a CAGR of 2.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases such as COVID-19, HIV, HBC, HCV, along with growing geriatric population is predicted to fuel the need for POC molecular diagnostics tests. Furthermore, rapid and accurate results offered by these POC tests act as a major factor for such growing acceptance across geographies. Moreover, rising emphasis for home care and assisted care facilities across emerging economies is also predicted boost POC molecular diagnostics market growth during the forecast years.

Global geriatric population is increasing, which is expected to boost the demand for POC molecular diagnostics. Estimates published by the WHO suggest that the global population of age group 65 years and above is expected to increase from 7% in 2000 to 16% in 2050. Aging elevates the risk of diseases such as cardiovascular and cancer. Therefore, increase in global geriatric population is expected to raise the demand for continuous monitoring via facilities requiring POC MDx, such as home healthcare and assisted living healthcare facilities. Japan and China are two of the most affected Asian countries, and a significant increase in Japan's geriatric population is anticipated. Currently, more than 20% of the country's population is over the age of 65 years.

Increasing prevalence of cancer across countries has resulted in a continuous demand for point-of-care molecular diagnostic tests within hospitals. According to the National Center for Chronic Disease Prevention and Health Promotion, the annual cancer cases are likely to grow from 1.53 million in 2015 to 2.28 million by 2050. CDC has predicted incidence is likely to increase by 50% owing to increasing population within the U.S. Furthermore, emergence of CRISPR and NGS techniques for cancer detection has improved the diagnosis rates tremendously. With increasing affordability of NGS in past decade has also benefited the POC molecular diagnostics market for oncology. Such factors are likely to drive the global market.

Major companies active in the POC molecular diagnostics market include Danaher, BioMerieux, Bio-Rad Laboratories, Inc., Abbott, F. Hoffmann-La Roche AG, BD, and many more. Large number of pilot programs being initiated are likely to bring new products in the market. For instance, in march 2022, Intermountain Healthcare announced that they will be rolling out a Galleri Multi-Cancer Early Detection Test for 50 of their employees as a pilot plan, with this the company is expecting to launch new product in order to improve their market position.

Point-of-Care Molecular Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology And Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Technology Business Analysis

Chapter 5. Application Business Analysis

Chapter 6. Test Location Business Analysis

Chapter 7. End-use Business Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â